|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
KR100221066B1
(ko)
|
1989-10-13 |
1999-10-01 |
스튜어트 엘.왓트 |
에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물
|
|
IL192290A0
(en)
|
1993-08-17 |
2008-12-29 |
Kirin Amgen Inc |
Erythropoietin analogs
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
CA2296770A1
(en)
|
1997-07-14 |
1999-01-28 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
|
US6548653B1
(en)
|
1998-06-15 |
2003-04-15 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
|
EP1124961B9
(en)
|
1998-10-23 |
2010-07-21 |
Kirin-Amgen Inc. |
Thrombopoietic compounds
|
|
HK1040944B
(en)
|
1998-10-23 |
2007-09-07 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
IL143266A0
(en)
|
1998-11-27 |
2002-04-21 |
Darwin Discovery Ltd |
Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same
|
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
|
EP1169352A4
(en)
|
1999-04-14 |
2005-05-04 |
Smithkline Beecham Corp |
ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
|
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
WO2001031007A2
(en)
|
1999-10-22 |
2001-05-03 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules derived from rat brain and programmed cell death models
|
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
|
AU2154401A
(en)
|
1999-11-12 |
2001-05-30 |
Merck Patent Gmbh |
Erythropoietin forms with improved properties
|
|
BRPI0107736B8
(pt)
|
2000-01-21 |
2021-05-25 |
Biovex Ltd |
cepa hsv1 js1, composição farmacêutica, e, uso de uma cepa hsv1 js1
|
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
AU5551601A
(en)
|
2000-04-21 |
2001-11-07 |
Amgen Inc |
Methods and compositions for the prevention and treatment of anemia
|
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
|
MXPA03001469A
(es)
|
2000-09-08 |
2004-12-13 |
Gryphon Therapeutics Inc |
Proteinas sinteticas estimulantes de la eritropoyesis.
|
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
|
EP1345628B1
(en)
|
2000-12-20 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
|
|
GEP20084484B
(en)
|
2001-01-05 |
2008-09-25 |
Pfizer |
Antibodies to insulin-like growth factor i receptor
|
|
CA2443373A1
(en)
|
2001-04-04 |
2002-10-31 |
Genodyssee |
New polynucleotides and polypeptides of the erythropoietin gene
|
|
EP1921088B1
(en)
|
2001-05-11 |
2014-10-08 |
Amgen Inc. |
Peptides and related molecules that bind to tall-1
|
|
TR201809008T4
(tr)
|
2001-06-26 |
2018-07-23 |
Amgen Fremont Inc |
Opgl ye karşi antikorlar.
|
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
|
EP1425389B1
(en)
|
2001-08-23 |
2011-11-02 |
Genmab A/S |
Human antibodies specific for interleukin 15 (il-15)
|
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
WO2003055526A2
(en)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Erythropoietin conjugates
|
|
AU2003216748B2
(en)
|
2002-01-18 |
2009-07-16 |
Pierre Fabre Medicament |
Novel anti-IGF-IR antibodies and uses thereof
|
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
|
EP1470232A1
(en)
|
2002-01-31 |
2004-10-27 |
Oxford Biomedica (UK) Limited |
Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia
|
|
EP1492878B1
(en)
|
2002-03-26 |
2007-05-30 |
Lek Pharmaceutical and Chemical Co. D.D. |
Process for the preparation of a desired erythropoietin glyco-isoform profile
|
|
WO2003084477A2
(en)
|
2002-03-29 |
2003-10-16 |
Centocor, Inc. |
Mammalian cdr mimetibodies, compositions, methods and uses
|
|
DE60328092D1
(de)
|
2002-03-29 |
2009-08-06 |
Kumiai Chemical Industry Co |
Acetolactatsynthase codierende gene
|
|
CA2485365A1
(en)
|
2002-05-13 |
2003-11-20 |
Modigenetech Ltd. |
Ctp-extended erythropoietin
|
|
MXPA04011624A
(es)
|
2002-05-24 |
2005-03-07 |
Schering Corp |
Anticuerpo neutralizante humano anti-igfr.
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
JP2006504406A
(ja)
|
2002-06-28 |
2006-02-09 |
セントカー・インコーポレーテツド |
哺乳動物のch1欠失ミメティボディ、組成物、方法および使用
|
|
US7241733B2
(en)
|
2002-06-28 |
2007-07-10 |
Centocor, Inc. |
Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
|
|
WO2004009627A1
(en)
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
|
WO2004018667A1
(ja)
|
2002-08-26 |
2004-03-04 |
Kirin Beer Kabushiki Kaisha |
ペプチド及びこれを含む医薬
|
|
JP4317817B2
(ja)
|
2002-09-06 |
2009-08-19 |
アムジェン インコーポレイテッド |
治療用ヒト抗il−1r1モノクローナル抗体
|
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
|
CA2496317C
(en)
|
2002-09-11 |
2014-02-18 |
Fresenius Kabi Deutschland Gmbh |
Method of producing hydroxyalkyl starch derivatives
|
|
CN1723053A
(zh)
*
|
2002-09-12 |
2006-01-18 |
儿童医院医疗中心 |
无痛药物注射的方法和设备
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
|
WO2004034988A2
(en)
|
2002-10-16 |
2004-04-29 |
Amgen Inc. |
Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
|
|
US6800070B2
(en)
*
|
2002-11-07 |
2004-10-05 |
George Mazidji |
Lockable tranquilizer bracelet
|
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
|
EA009056B1
(ru)
|
2002-12-20 |
2007-10-26 |
Амген, Инк. |
Связывающие агенты, ингибирующие миостатин
|
|
EP1603948A1
(en)
|
2003-03-14 |
2005-12-14 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
|
JP4473257B2
(ja)
|
2003-04-02 |
2010-06-02 |
エフ.ホフマン−ラ ロシュ アーゲー |
インスリン様成長因子i受容体に対する抗体及びその使用
|
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
AU2004238869B2
(en)
|
2003-05-12 |
2009-06-25 |
Affymax, Inc. |
Novel poly(ethylene glycol) modified compounds and uses thereof
|
|
PT1625156E
(pt)
|
2003-05-12 |
2013-01-09 |
Affymax Inc |
Novos péptidos que se fixam ao receptor da eritropoietina
|
|
CN100441595C
(zh)
|
2003-05-12 |
2008-12-10 |
阿费麦克斯公司 |
结合红细胞生成素受体的新肽
|
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
|
US6995245B2
(en)
|
2003-05-30 |
2006-02-07 |
Centocor, Inc. |
Formation of novel erythropoietin conjugates using transglutaminase
|
|
WO2005001136A1
(en)
|
2003-06-04 |
2005-01-06 |
Irm Llc |
Methods and compositions for modulating erythropoietin expression
|
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
|
TWI382031B
(zh)
|
2003-07-15 |
2013-01-11 |
Amgen Inc |
作為選擇性神經生長因子(ngf)通道抑制劑之人類抗-ngf中和抗體
|
|
CN103880955A
(zh)
|
2003-07-18 |
2014-06-25 |
安姆根有限公司 |
肝细胞生长因子的特异性结合物
|
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
|
GB0317511D0
(en)
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
|
JP2007512001A
(ja)
|
2003-08-28 |
2007-05-17 |
バイオレクシス ファーマシューティカル コーポレイション |
Epoミメティックペプチドおよび融合タンパク質
|
|
WO2005081687A2
(en)
|
2003-09-30 |
2005-09-09 |
Centocor, Inc. |
Human hinge core mimetibodies, compositions, methods and uses
|
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
|
CN100586414C
(zh)
|
2003-10-21 |
2010-02-03 |
诺沃挪第克公司 |
具有倾斜针的储器装置
|
|
TWI356064B
(en)
|
2003-11-07 |
2012-01-11 |
Immunex Corp |
Antibodies that bind interleukin-4 receptor
|
|
AR046639A1
(es)
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
|
NZ547168A
(en)
|
2003-11-24 |
2010-05-28 |
Biogenerix Ag |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
|
EP1548031A1
(en)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Nature-identical erythropoietin
|
|
BRPI0417916A
(pt)
|
2003-12-31 |
2007-04-10 |
Merck Patent Gmbh |
proteìna de fusão de fc-eritropoietina com farmacocinética melhorada
|
|
AU2004311796A1
(en)
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Novel recombinant proteins with N-terminal free thiol
|
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
|
US20050187158A1
(en)
|
2004-01-22 |
2005-08-25 |
Ranby Mats G. |
Pharmaceutical composition
|
|
WO2005084711A1
(en)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
A pegylated recombinant erythropoietin that has in vivo activity
|
|
AR048918A1
(es)
|
2004-03-11 |
2006-06-14 |
Fresenius Kabi De Gmbh |
Conjugados de almidon de hidroxietilo y eritropoyetina
|
|
CA2560889A1
(en)
|
2004-03-23 |
2005-10-13 |
Sanjay D. Khare |
Monoclonal antibodies specific for human ox40l (cd 134l)
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
US20080194475A1
(en)
|
2004-04-23 |
2008-08-14 |
Andrew Buchanan |
Erythropoietin Protein Variants
|
|
EP1781697B1
(en)
|
2004-07-07 |
2009-04-22 |
H.Lundbeck A/S |
Novel carbamylated epo and method for its production
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
WO2006029094A2
(en)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
|
CA2586915A1
(en)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules which promote hematopoiesis
|
|
NZ555256A
(en)
*
|
2004-11-22 |
2011-07-29 |
Intelliject Inc |
Housing, typically similar to credit card size, with compressed gas container, medicament container(s) for user to inject medicament
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
US7906625B2
(en)
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
PL2100614T3
(pl)
|
2005-06-17 |
2014-02-28 |
Imclone Llc |
Przeciwciała przeciwko PDGFR alfa do zastosowania w leczeniu guzów nowotworowych
|
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
|
EP2388276A3
(en)
|
2005-07-18 |
2013-11-27 |
Amgen, Inc |
Human anti-B7RP1 neutralizing antibodies
|
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
GB0603683D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
|
US7851438B2
(en)
|
2006-05-19 |
2010-12-14 |
GlycoFi, Incorporated |
Erythropoietin compositions
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
EP2106261A4
(en)
|
2006-11-07 |
2010-05-26 |
Merck Sharp & Dohme |
ANTAGONISTS OF PCSK9
|
|
CA2667869A1
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
US20100041102A1
(en)
|
2006-11-07 |
2010-02-18 |
Ayesha Sitlani |
Antagonists of pcsk9
|
|
WO2008057457A2
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
|
AR064333A1
(es)
|
2006-12-14 |
2009-04-01 |
Schering Corp |
Anticuerpo anti-tslp de diseno
|
|
CA2681428A1
(en)
|
2007-04-13 |
2008-10-23 |
Novartis Ag |
Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
WO2008133702A1
(en)
|
2007-04-30 |
2008-11-06 |
Medtronic Minimed, Inc. |
Needle inserting and fluid flow connection for infusion medium delivery system
|
|
US8323250B2
(en)
*
|
2007-04-30 |
2012-12-04 |
Medtronic Minimed, Inc. |
Adhesive patch systems and methods
|
|
PE20090768A1
(es)
|
2007-06-20 |
2009-07-09 |
Irm Llc |
Metodos y composiciones para el tratamiento de enfermedades alergicas
|
|
US8303545B2
(en)
*
|
2007-09-07 |
2012-11-06 |
Stat Medical Devices, Inc. |
Infusion device and method of using and making the same
|
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
|
SG2013014352A
(en)
|
2007-10-26 |
2014-09-26 |
Merck Sharp & Dohme |
Anti-pcsk9 and methods for treating lipid and cholesterol disorders
|
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
|
EP2480576A4
(en)
|
2009-09-25 |
2013-04-10 |
Merck Sharp & Dohme |
PCSK9 ANTAGONISTS
|
|
CA2777542A1
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Ax213 and ax132 pcsk9 antagonists and variants
|
|
EP2493505A4
(en)
|
2009-10-30 |
2013-06-12 |
Merck Sharp & Dohme |
Ax1 and ax189 pcsk9 antagonists and variants
|
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
|
SG183867A1
(en)
|
2010-03-11 |
2012-10-30 |
Rinat Neuroscience Corp |
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
|
|
WO2011116304A1
(en)
|
2010-03-19 |
2011-09-22 |
Halozyme, Inc. |
Gas-pressured medication delivery device
|
|
WO2012054438A1
(en)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
|
MX2013007168A
(es)
|
2010-12-22 |
2013-11-04 |
Genentech Inc |
Anticuerpo anti-pcsk9 y metodos de uso.
|
|
WO2012101252A2
(en)
|
2011-01-28 |
2012-08-02 |
Sanofi |
Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
|
|
EA201391157A1
(ru)
|
2011-02-11 |
2014-02-28 |
АйАрЭм ЭлЭлСи |
Антагонисты pcsk9
|
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
|
US20160067347A1
(en)
|
2012-12-20 |
2016-03-10 |
Amgen Inc. |
Apj receptor agonists and uses thereof
|
|
MX380644B
(es)
|
2013-03-14 |
2025-03-12 |
Amgen Inc |
Composiciones y metodos de variantes de inhibidor tisular de la metaloproteinasa tipo tres (timp-3).
|
|
US20140274874A1
(en)
|
2013-03-14 |
2014-09-18 |
Amgen Inc. |
Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
|
|
DK3057630T3
(en)
|
2013-10-18 |
2019-04-29 |
Sanofi Aventis Deutschland |
INJECTION DEVICE FOR ADMINISTRATION OF A LIQUID MEDICINE WITH MEDICINAL CONTAINER SHIFT
|
|
JP6542805B2
(ja)
*
|
2014-04-24 |
2019-07-10 |
ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company |
輸液デバイス用のカニューレ挿入および引込デバイス
|